$10.65
+0.24 (+2.31%)
Open$10.65
Previous Close$10.41
Day High$10.92
Day Low$10.43
52W High$22.55
52W Low$9.69
Volume—
Avg Volume238.5K
Market Cap210.78M
P/E Ratio—
EPS$-3.01
SectorBiotechnology
Analyst Ratings
Buy
14 analysts
Price Target
+85.0% upside
Current
$10.65
$10.65
Target
$19.70
$19.70
$13.49
$19.70 avg
$20.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 133.88M | 4.38M | 103.26M |
| Net Income | 47.73M | -207,966,613 | -15,524,708 |
| Profit Margin | 35.7% | -5,013.7% | -15.0% |
| EBITDA | 37.89M | -245,260,567 | -22,220,211 |
| Free Cash Flow | — | — | -17,331,210 |
| Rev Growth | — | -43.9% | +11.8% |
| Debt/Equity | — | — | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |